Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2009, Vol. 14 ›› Issue (6): 642-645.

Previous Articles     Next Articles

Protective effects of diammonium glycyrrhizinate phospholipid complex on chronic liver injury

RU Ren-ping1, CHEN Xiao-jin1, YOU Lin-ya1, TANG Hong-ying1, CAI Han-ping1, KUANG Rong2   

  1. 1Pharmacy of the Sixth People's Hospital of Hangzhou, Hangzhou 310004, Zhejiang, China;
    2Zhejiang Institute for Food and Drug Control, Hangzhou 310004, Zhejiang, China
  • Received:2009-05-21 Revised:2009-06-25 Online:2009-06-26 Published:2020-10-27

Abstract: AIM: To approach the protective effects of diammonium glycyrrhizinate phospholipid complex injection (DG-PC)on chronic and immunological liver injury. METHODS: The chronic and immunological hepatic liver injury was established in C57BL/6J mice, the levels of ALT, AST, TP,ALB and HA in serum were determined, the contents of SOD,GSH and collagen 1 (C.I)in liver homogenate were detected, and the liver tissue sections were observed by electron microscope. RESULTS: Compared with DG, DG-PC could significantly improve the AST level, increase the content of ALB, increase the A/G, decrease the content of HA(P<0.01), improve the activities of SOD and GSH(P<0.01).The therapeutic efficacy of DG-PC was better than that of DG.As to microstructure, DGPC could protect the hepatic cell and organelle, and relieve the fibrosis level. CONCLUSION: DG-PC has protective effects on chronic and immunological liver damage to C57 BL/6J mice, which maybe relate to the antioxidant effects.

Key words: diammonium glycyrrhizinate phospholipid complex, chronic and immunological liver injury, ultrastructure

CLC Number: